{"id":15531,"date":"2026-09-15T18:57:36","date_gmt":"2026-09-15T18:57:36","guid":{"rendered":"https:\/\/medical-article.com\/?p=15531"},"modified":"2026-09-15T18:57:36","modified_gmt":"2026-09-15T18:57:36","slug":"gsk-commits-750m-to-get-chimagens-phase-1-ready-drug-for-multiple-myeloma","status":"publish","type":"post","link":"https:\/\/medical-article.com\/?p=15531","title":{"rendered":"GSK Commits $750M to Get Chimagen\u2019s Phase 1-Ready Drug for Multiple Myeloma"},"content":{"rendered":"<p><a href=\"https:\/\/medcitynews.com\/2026\/09\/gsk-chimagen-trispecific-t-cell-engager-multiple-myeloma-cancer-tce\/\"><\/a><\/p>\n<p>GSK is acquiring global rights to a T cell engager that Chimagen Biosciences developed to hit three targets. GSK believes this tri-specific approach could offer advantages over currently available drugs that hit two targets, but other big pharma companies are also developing trispecific antibodies. <\/p>\n<p>The post <a href=\"https:\/\/medcitynews.com\/2026\/09\/gsk-chimagen-trispecific-t-cell-engager-multiple-myeloma-cancer-tce\/\">GSK Commits $750M to Get Chimagen\u2019s Phase 1-Ready Drug for Multiple Myeloma<\/a> appeared first on <a href=\"https:\/\/medcitynews.com\/\">MedCity News<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>GSK is acquiring global rights to a T cell engager that Chimagen Biosciences developed to hit three targets. GSK believes this tri-specific approach could offer advantages over currently available drugs that hit two targets, but other big pharma companies are also developing trispecific antibodies. The post GSK Commits $750M to Get Chimagen\u2019s Phase 1-Ready Drug&#8230;<\/p>\n","protected":false},"author":0,"featured_media":15532,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-15531","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicine"],"_links":{"self":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/15531"}],"collection":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15531"}],"version-history":[{"count":0,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/15531\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/media\/15532"}],"wp:attachment":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15531"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15531"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15531"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}